`Case T:22-cv-O0061-TSK BocumentS Filed 08/03/22 Page Lof2 PagelD # 1740
`
`TRADEMARK
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`filed in the U.S. District Court
`Northern District of West Virginia
`on the following
`[Trademarks or
` [Patents.
`the patent action involves 35 U.S.C. § 292.):
`(
`[1]
`
`DOCKET NO.
`1:22-cv-61
`PLAINTIFF
`
`DATE FILED
`8/2/2022
`
`U.S. DISTRICT COURT
`Northern District of West Virginia
`DEFENDANT
`
`:
`
`
`
`REGENERON PHARMACEUTICALS, INC.
`MYLAN PHARMACEUTICALS, INC.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`DATE INCLUDED
`
`In the above—entitled case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK NO
`
`(1 Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`C) Answer
`
`C1 Cross Bill
`
`(1 Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`
`
`1 2 3
`
`5
`
`In the above—entitled case, the following decision has been rendered or judgementissued:
`
`CLERK
`CHERYL DEAN RILEY
`
`(BY) DEPUTY CLERK
`/s/ D. Kinsey
`
`DATE
`
`8/3/2022
`
`Copy 1—Uponinitiation of action, mail this copy to Director Copy 3—Upon termination of action, mail this copy to Director
`Copy 2—Uponfiling document adding patent(s), mail this copy to Director Copy 4—Casefile copy
`
`
`
`
` 4
`
`DECISION/JUDGEMENT
`
`
`
`
`Case l22-cv-O00061-TSK BocumentS Filed 08/03/22 Page 2of2 PagelD a: 1742
`
`
`
`
`
`
`
`
`PATENT OR
`TRADEMARK NO.
`7,070,959
`9,222,106
`9,254,338
`9,669,069
`9,816,110
`10,130,681
`10,406,226
`10,415,055
`10,464,992
`
`DATE OF PATENT
`OR TRADEMARK
`July
`4, 2006
`December 29, 2015
`February 9, 2016
`June 6, 2017
`November14, 2017
`November 20, 2018
`September 10, 2019
`September 17, 2019
`November5, 2019
`
`HOLDER OF PATENT OR
`TRADEMARK
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`Regeneron Pharmaceuticals, Inc
`
`11,332,771
`
`May 17, 2022
`
`Regeneron Pharmaceuticals, Inc
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`